Article
Document
Anualidad
Academic Article
Information Content Entity
Continuant
Entity
Generically Dependent Continuant
Simplification to dual therapy (atazanavir/ritonavir¿+¿lamivudine) versus standard triple therapy [atazanavir/ritonavir¿+¿two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
RDF description of Simplification to dual therapy (atazanavir/ritonavir¿+¿lamivudine) versus standard triple therapy [atazanavir/ritonavir¿+¿two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study) - http://research.umh.es/vivo/pub/articulo/179690